PET Imaging

Overview

Positron emission tomography uses radiotracers to image metabolic activity. It provides functional information about tissues. It is often combined with CT or MRI for localization.

Clinical Applications

PET is used in oncology neurology and cardiology. It detects metabolic activity of tumors and brain disorders. It guides therapy selection and response assessment.

Radiotracers

Common tracers include FDG and others for specific targets. Tracer selection depends on clinical question. Radiochemistry advances expand tracer availability.

Hybrid Imaging

PET CT and PET MRI combine functional and anatomic data. These hybrids improve diagnostic accuracy and staging. They are valuable in complex cases.

Molecular Imaging

Overview

Molecular imaging visualizes biological processes at the cellular and molecular level. It uses targeted radiotracers and probes to reveal disease biology. These techniques complement anatomic imaging for precision medicine.

Tracer Development

Tracer selection depends on the molecular target and clinical question. New tracers enable imaging of receptors metabolism and cellular pathways. Regulatory and production considerations affect clinical availability.

Clinical Applications

Molecular imaging aids in oncology neurology and cardiology applications. It can detect early disease and monitor targeted therapies. Integration with PET CT and PET MRI enhances localization.

Future Directions

Advances include novel tracers and hybrid imaging platforms. Quantitative molecular imaging supports personalized treatment strategies. Research continues to expand clinical indications and accessibility.